Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation

MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

View More »

Google Scholar citation report
Citations : 2051

Journal of Vaccines & Vaccination received 2051 citations as per Google Scholar report

Flyer image
Journal of Vaccines & Vaccination peer review process verified at publons
Flyer image
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Open Access Journals
View More

Nathalie Garcon

Nathalie Garcon

Glaxo Smith Kline Biologicals, Wavre, Belgium

Biography
Nathalie Garçon currently serves as the CSO for Technology research institute BIOASTER, dealing with technologies to accelerate the development and availability of new solutions in infectiology. Previously, Dr Garcon served as the  Vice President and Head of Global Adjuvant and technologies innovation centers at GSK vaccines. Following the successful completion of two PhDs, one in biological pharmacy and the other in immunotoxicology and immunopharmacology, Dr Garçon moved to the UK for 1 year as a postdoctoral research fellow at the Royal Free Hospital in London, undertaking research on liposomes in vaccines.